A Study of CTA30X Cell Injection in Patients With Relapsed or Refractory CD19-positive B-line Hematological Malignancies
Clinical trial NCT04689204 · COMPLETED
Trial details
- NCT number
- NCT04689204
- Sponsor
- He Huang
- Status
- COMPLETED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-29
- Primary completion
- 2022-12-29
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.